# MAGE-A4-directed TCR-T in the Treatment Amongst Subjects With Advanced Solid Tumors

> **NCT06170294** · PHASE1 · RECRUITING · sponsor: **Peking University** · enrollment: 20 (estimated)

## Conditions studied

- Advanced Solid Tumor

## Interventions

- **DRUG:** TCR-MAGE-A4 T-Cells

## Key facts

- **NCT ID:** NCT06170294
- **Lead sponsor:** Peking University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-01-01
- **Primary completion:** 2025-12-31
- **Final completion:** 2028-12-31
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2023-12-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06170294

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06170294, "MAGE-A4-directed TCR-T in the Treatment Amongst Subjects With Advanced Solid Tumors". Retrieved via AI Analytics 2026-06-15 from https://api.ai-analytics.org/clinical/NCT06170294. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*